American Tower to Present at Upcoming June Conferences
BOSTON--(BUSINESS WIRE)--American Tower Corporation (NYSE: AMT) today announced that it is scheduled to present at the following investor conferences:
Nareit's REITweek: 2025 Investor Conference in New York, New York
Wednesday, June 11, 2025, 9:45 a.m. ET – Mizuho Technology Conference 2025 in New York, New York
A live webcast and replay of the presentation will be accessible from the Investor Relations section of American Tower's website at www.americantower.com/investor-relations.
American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 149,000 communications sites and a highly interconnected footprint of U.S. data center facilities. For more information about American Tower, please visit www.americantower.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
41 minutes ago
- Business Wire
Versa and OPSWAT Partner to Enhance Real-Time Device Security for SASE
SANTA CLARA, Calif.--(BUSINESS WIRE)--Versa, the global leader in Universal Secure Access Service Edge (SASE), today announced a technology partnership with OPSWAT, a global leader in critical infrastructure protection (CIP) cybersecurity solutions, to enhance the real-time device security monitoring capabilities of the Versa SASE Client. Versa and OPSWAT partner to enhance real-time device security for SASE, with OPSWAT MetaDefender SDK extending Versa's SASE endpoint capabilities for Zero Trust enforcement to reduce attack surface risk. Share The Versa SASE Client combines connectivity and security for users and their devices, enabling real-time best-path routing and the enforcement of dynamic security policies based on Zero Trust and continuously evaluated device security posture. As a result of this partnership, Versa has integrated OPSWAT's MetaDefender Endpoint Security SDK into the Versa SASE Client, allowing IT teams to leverage real-time device posture data to automatically validate endpoints and enforce Zero Trust policies – helping to reduce the attack surface. 'Remote workers and BYOD users need access to critical business systems and data; however, this increases organizations' threat risks if endpoint devices are not secure,' said Anusha Vaidyanathan, Senior Director of Product Management at Versa. 'This partnership enables Versa customers to apply OPSWAT's MetaDefender Endpoint Security SDK directly within our VersaONE Universal SASE Platform. As businesses continue to operate in cloud and hybrid settings, this joint solution enables IT teams to minimize risk by verifying device security and compliance policies before granting access to secure company systems.' A newly published video featuring an interview with Ms. Vaidyanathan explains the integration and summarizes its benefits. For more information, see 'Our partnership with Versa validates OPSWAT's commitment to securing critical infrastructure by integrating advanced endpoint compliance capabilities directly into the VersaONE Universal SASE Platform,' said Hamid Karimi, Vice President of Technical Alliances and OEM at OPSWAT. 'With OPSWAT MetaDefender Endpoint Security SDK, Versa customers can confidently ensure device compliance and security before network access, providing better defense against today's evolving cybersecurity threats.' The MetaDefender SDK is a cross-platform, versatile, and modular framework that serves as a powerful endpoint security software development platform, enabling software engineers and technology vendors to build advanced endpoint security products. The SDK's Device Compliance Module enables software engineers to implement features in their products for a wide range of applications, including device posture assessment, as well as for potentially unwanted applications, allowing them to deliver better secure remote access, compliance, network access control, remote support, and other capabilities to their end customers. Availability The Versa SASE Client with OPSWAT enhancements is currently available as part of the Versa Universal SASE Platform. For more information, see About OPSWAT For the last 20 years OPSWAT, a global leader in IT, OT, and ICS critical infrastructure cybersecurity, has continuously evolved an end-to-end solutions platform that gives public and private sector organizations and enterprises the critical advantage needed to protect their complex networks and ensure compliance. Empowered by a 'Trust no file. Trust no device.™' philosophy, OPSWAT solves customers' challenges around the world with zero-trust solutions and patented technologies across every level of their infrastructure, securing their networks, data, and devices, and preventing known and unknown threats, zero-day attacks, and malware. Discover how OPSWAT protects the world's critical infrastructure and helps secure our way of life; visit About Versa Versa, a global leader in SASE, enables organizations to create self-protecting networks that radically simplify and automate their network and security infrastructure. Powered by AI, the VersaONE Universal SASE Platform delivers converged SSE, SD-WAN, and SD-LAN solutions that protect data and defend against cyberthreats while delivering a superior digital experience. Thousands of customers globally, with hundreds of thousands of sites and millions of users, trust Versa with their mission critical networks and security. Versa is privately held and funded by investors such as Sequoia Capital, Mayfield, and BlackRock. For more information, visit and follow Versa on LinkedIn and X (Twitter) @versanetworks. Versa Networks, VOS, the Versa logo, and Versa Titan are or may be registered trademarks of Versa Networks, Inc.
Yahoo
41 minutes ago
- Yahoo
Robin Vince Elected Chairman of BNY's Board of Directors
NEW YORK, June 12, 2025 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, today announced that Chief Executive Officer Robin Vince was unanimously elected by the Board of Directors ("the Board") to the additional position of Chairman, and Joe Echevarria, the current Chairman, as lead independent director, effective September 1, 2025. Joe Echevarria previously held the lead independent director role from 2016 to 2019. "Since stepping into his role almost three years ago, Robin has demonstrated why the Board chose him as CEO. He has a rigorous approach to strategy and execution, along with an unwavering dedication to serving clients and creating value for shareholders," said Joe Echevarria, Independent Chairman. Robin Vince joined the Board of Directors of BNY and became Chief Executive Officer on August 31, 2022. In the role of Chairman, Robin will lead the work to set the agenda for the board, leveraging his deep understanding of BNY's business to continue the firm's transformation, drive strategy and manage risk. As the lead independent director, Joe Echevarria's responsibilities will include acting as a liaison between independent directors and the Chairman and CEO, providing input on behalf of the independent directors on board agendas, calling meetings of the independent directors and setting agendas for executive sessions and meetings of independent directors. "I'm grateful for the leadership of Joe and the entire Board of Directors, and I look forward to our continued collaboration," said Robin Vince, BNY CEO and Chairman-elect. "I am confident in our company's trajectory and see tremendous opportunity ahead as we continue to deliver for our clients, embrace new ways of working and come together as one BNY." MediaAnneliese Diedrichs +44 7930 135 524 InvestorsMarius Merz +1 212 298 1480 BNY BNY is a global financial services company that helps make money work for the world – managing it, moving it and keeping it safe. For more than 240 years BNY has partnered alongside clients, putting its expertise and platforms to work to help them achieve their ambitions. Today BNY helps over 90% of Fortune 100 companies and nearly all the top 100 banks globally to access the money they need. BNY supports governments in funding local projects and works with over 90% of the top 100 pension plans to safeguard investments for millions of individuals, and so much more. As of March 31, 2025, BNY oversees $53.1 trillion in assets under custody and/or administration and $2.0 trillion in assets under management. BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Headquartered in New York City, BNY has been named among Fortune's World's Most Admired Companies and Fast Company's Best Workplaces for Innovators. Additional information is available on Follow on LinkedIn or visit the BNY Newsroom for the latest company news. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, which may be expressed in a variety of ways, including the use of future or present tense language, relate to, among other things, BNY's strategic priorities and opportunities. These statements are not guarantees of future results or occurrences, are inherently uncertain and are based upon current beliefs and expectations of future events, many of which are, by their nature, difficult to predict, outside of BNY's control and subject to change. Actual results may differ, possibly materially, from the anticipated results expressed or implied in these forward-looking statements as a result of a number of important factors, including, but not limited to, the factors identified above and the risk factors and other uncertainties set forth in BNY's Annual Report on Form 10-K for the year ended December 31, 2024, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 and BNY's other filings with the Securities and Exchange Commission. All statements in this press release speak only as of the date on which such statements are made and BNY undertakes no obligation to update the information to reflect events or circumstances that arise after that date or to reflect the occurrence of unanticipated events. View original content: SOURCE BNY
Business Wire
44 minutes ago
- Business Wire
Genesis Therapeutics Appoints Aleksandra Faust as Chief Artificial Intelligence Officer
BURLINGAME, Calif.--(BUSINESS WIRE)-- Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for the treatment of severe diseases, today announced the appointment of Aleksandra Faust, Ph.D., as Chief AI Officer. Dr. Faust joins Genesis with more than 20 years of leadership experience in the AI and tech industries, developing machine learning (ML) for complex systems such as robotics and autonomous vehicles. She most recently served as Director of Research at Google DeepMind, overseeing foundational model learning research and contributing to Gemini and to generalist web agents, among many other key innovations in her tenure. In her previous roles, she co-founded reinforcement learning research at Google Brain, founded task and motion planning research in Robotics at Google, led machine learning for self-driving car planning and controls at Waymo, and was a principal investigator at Sandia National Laboratories. 'We are excited to welcome Aleksandra to our world-class team of scientists, engineers and innovators,' said Evan Feinberg, Ph.D., founder and CEO of Genesis. 'As an established industry leader and pioneer in fundamental AI research across multiple complex domains, Aleksandra will play an instrumental role in elevating our GEMS platform's suite of generative and predictive AI technologies.' Dr. Faust earned a Ph.D. and a Master's degree in Computer Science from the University of New Mexico, and the University of Illinois at Urbana-Champaign, respectively. She has co-authored over 60 publications, the high impact of which is reflected in her h-index of 40, and her research has been featured in The New York Times and Forbes. Dr. Faust has also been recognized with numerous honors, including the IEEE Robotics and Automation Society Early Career Award and being named a Distinguished Alumna by the University of New Mexico School of Engineering. 'I am thrilled to join Genesis in its mission to usher in a new era of drug discovery with AI,' said Dr. Faust. 'The company's GEMS platform exemplifies how advanced machine learning can be synthesized with physics to enable the discovery of novel small molecule compounds that could produce breakthrough medicines for patients. I look forward to working with the talented Genesis team to push the boundaries of what is possible.' About Genesis Therapeutics Genesis Therapeutics, Inc. is an AI-focused biotechnology company leveraging its generative and predictive AI platform, GEMS (Genesis Exploration of Molecular Space), for small molecule drug discovery. GEMS integrates proprietary AI methods, including language models, diffusion models and physical simulation, to generate and optimize molecules for complex targets. Genesis has raised over $300 million from leading life science, tech, and AI-focused investors, and is building a therapeutics pipeline for a variety of high-impact targets. Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. For more information on Genesis, please visit the company's website at
